
|Articles|March 15, 2003
Guidelines aim to clear confusion over ad claims
Baltimore-Taking a firm stance against deceptive advertising for LASIK and other ophthalmic procedures, Matthew Daynard, Esq., outlined Federal Trade Commission (FTC) advertising requirements at the Current Concepts in Ophthalmology meeting, sponsored by Johns Hopkins University School of Medicine, here.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
AAO 2025: Kenneth C. Fan, MD, sees vision gains with MCO-010 in Stargardt disease
3
AAO 2025: Understanding and diagnosing endophthalmitis
4
AAO 2025: Diana Do reviews the real-world use of aflibercept 8 mg
5